Danimer Scientific Inc (DNMR) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access DNMR Annual Cash Flow →
The table below presents a historical view of Danimer Scientific Inc's cash flow activity, supporting analysis of liquidity trends over time.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2024)
9 Months
(Jun 30 2024) (Mar 31 2024) (Dec 31 2023) (Sep 30 2023)
Operating Activities
Income-71.76
Depreciation & amortization22.35
Amortization of Other Assets8.95
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-1.29
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets, Total0.00
Share-based Compensation1.69
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction-12.46
Operating Lease Right Of Use Asset Amortization Expense-
Interest Incurred But Not Paid-
Loss On Writeoff Of Deferred Loan Costs-
Lease Cost Benefit-
Increase Decrease In Contract With Customer Asset-0.76
Inventory Reserves0.51
Gain Loss On Forgiveness Of Debt-
Amortization Of Right Of Use Assets And Lease Liability-0.12
Loss On Extinguishment Of Debt-
Warrant Issuance Costs0.87
Increase Decrease In Contract With Customer Liability-0.09
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable3.40
Increase (Decrease) in Accounts Payable-0.64
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities1.59
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expenses, Other-0.24
Other Working Capital0.29
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities1.24
Discontinued operations0.00
Net Cash flow from Operating Activities-46.46
Investing Activities
Capital Expenditures-7.49
Sale of Capital Items1.17
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Payments for (Proceeds from) Loans Receivable, Total0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-6.32
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-1.10
Long-term debt - borrowings0.00
Long-term debt - repayments3.12
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock8.89
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-0.03
Sale Of Net Of Underwriting Discounts And Offering Costs-
Private Placement Warrants-
Payment Of Offering Costs-
Increase Decrease Transacttion Costs Related To Business Combination And P I P E Offering-
Increase Decrease Principal Payments On Longterm Debt-
Proceeds From Employee Stock Purchase Plan0.18
Proceeds Costs From Issuance Of Common Stock Net Of Issuance Costs4.52
Payments Related To Warrants Costs-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities15.58
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-52.78
Total Cash Flow-37.20
4 historic quarters locked

Sign in to unlock the full Danimer Scientific Inc cash flow history.

About Danimer Scientific Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20240930)
  • Filed with the SEC: November 19, 2024
  • Source: dnmr-20240930.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000950170-24-128298

Figures are derived from filed reports and may be restated. Historical data is subject to revision.